Non-Hodgkin Lymphoma Therapeutics Market - Top Companies and Manufacturers

Companies Dominating the Non-Hodgkin Lymphoma Therapeutics Market

AbbVie, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Teva Pharmaceutical Industries Ltd.
Sanofi
Pfizer Inc.
GSK plc.
Novartis AG
Bayer AG
Bausch Health Companies Inc.
Sun Pharmaceutical Industries Ltd.
Aurobindo Pharma
SIRPant Immunotherapeutics Inc.

Browse Key Market Insights with Data Illustration:

Non-Hodgkin Lymphoma Therapeutics Market Size & Share, Growth Forecasts 2037

In the News

SIRPant-M's investigational new drug (IND) application got FDA approval in May 2023 after reviewing preclinical data that indicated the medication was effective against a range of solid tumours as well as hematologic tumours.
AbbVie announced that EPKINLYTM (epcoritamab-bysp), the first and only T-cell engaging bispecific antibody, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with high-grade B-cell lymphoma (HGBL) and diffuse large B-cell lymphoma (DLBCL) that have undergone two or more lines of systemic therapy and are relapsed or refractory (R/R).

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of non-hodgkin lymphoma therapeutics is assessed at USD 10.68 billion.

The non-hodgkin lymphoma therapeutics market size was valued at USD 10.07 billion in 2024 and is expected to reach USD 26.1 billion by 2037, registering around 7.6% CAGR during the forecast period i.e., between 2025-2037. The market growth is propelled by surge in geriatric population, rise in environmental exposure, and growth in approval of medications.

North America industry is likely to account for largest revenue share of 30% by 2037, due to growing advancement and adoption of latest technology such as AI in the region.

The major players in the market are AbbVie, Inc., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc. are and others.

Non-Hodgkin Lymphoma Therapeutics Market - Top Companies and Manufacturers

Companies Dominating the Non-Hodgkin Lymphoma Therapeutics Market

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the non-hodgkin lymphoma therapeutics market worth?

Why is the demand for non-hodgkin lymphoma therapeutics growing?

Which region dominated the majority of non-hodgkin lymphoma therapeutics industry share?

Who are the top non-hodgkin lymphoma therapeutics companies?